Rev. OFIL 2017, 27;4:401-402
Fecha de recepción: 31/01/2017 – Fecha de aceptación: 02/03/2017
Navarro Dávila MA1, Anmad Shihadeh L2, Viña Romero MM1, Merino Alonso FJ1
1 Servicio de Farmacia
2 Servicio de Cardiología
Hospital Universitario Nuestra Señora de la Candelaria. Santa Cruz de Tenerife (España)
____
Correspondencia:
Marco Antonio Navarro Dávila
Avenida del Rosario, 145
38010 Santa Cruz de Tenerife
Correo electrónico: Mand_1989@hotmail.com
____
SUMMARY
Susac’s syndrome is a microangiopathy of the retina, inner ear and brain manifesting as a triad of encephalopathy, hearing loss and branch retinal artery occlusion. The pathological mechanism is thought to be an immune-mediated small vessel vasculitis with some pathophysiological similarity to dermatomyositis. Awareness and early recognition of this syndrome is important as early treatment with immunosuppression can minimise cognitive, audiological and visual sequelae. We report a case of a 47-year-old woman who presented with the characteristic syndrome. She was treated with immunomodulatory therapy and rituximab.
Key Words: Susac’s syndrome, autoinmune microangiopathy, clinical case, treatment.
____
Download PDF: Síndrome de Susac: papel de rituximab